INFECTIOUS DISEASE DIAGNOSTICS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Infectious Disease Diagnostics Market - Overview Providing diagnosis based only on symptoms is challenging, as two or more diseases can exhibit similar symptoms and therefore diagnostic tests are used for confirmation of the disease. The global Infectious Disease Diagnostics Market is estimated to account for US$ 1,131.4 Mn in terms of value in 2020 and is expected to reach US$ 1,841.2 Mn by the end of 2027. Global Infectious Disease Diagnostics Market: Drivers For instance, in January 2018, The Foundation for Innovative New Diagnostics collaborated with Becton, Dickinson, and Company (BD), Fondation Botnar, the Global Antibiotic Research & Development Partnership (GARDP), the Drugs for Neglected Diseases Initiative (DNDi), and the South African Medical Research Council (SAMRC) to address antimicrobial resistance (AMR) by accelerating the use of diagnostics. Global Infectious Disease Diagnostics Market: Opportunities For instance, in February 2020, Department of Health and Human Services announced a federal grant of US$ 750,000 to the city of Austin to help fight the spread of HIV/AIDS in Texas, U.S. Browse Research Reports: https://www.coherentmarketinsights.com/marketinsight/infectious-disease-diagnostics-market-1971 © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Key Takeaways: The cell cultures segment in the global infectious disease diagnostics market was valued at US$ 362.3 Mn in 2018 and is expected to reach US$ 747.4 Mn by 2027 at a CAGR of 8.3% during the forecast period. Several types of infections can be diagnosed using cell culture, where, microbes are grown in a laboratory setting to identify the same.
The STDs segment held dominant position in the global infectious disease diagnostics market in 2018, accounting for 32.8% share in terms of value, followed by CNS infection, and respiratory infections, respectively. Increasing sexually transmitted disease burden is fueling growth of the segment. Among 20 STDs, the most common are Gonorrhea, Chlamydia, Syphilis, Herpes, Hepatitis (HBV), and Human Immunodeficiency Virus (HIV). For instance, according to Centers for Disease Control and Prevention (CDC), in year 2016, 1,598,354 cases of Chlamydia trachomatis infection were reported in the U.S., corresponding to 497.3 cases per 100,000 in 2015. Diagnostic centers segment in the global infectious disease diagnostics market was valued at US$ 462.1 Mn in 2018 and is expected to reach US$ 958.7 Mn by 2027 at a CAGR of 8.5% during the forecast period. Central diagnostic laboratories are well equipped with latest diagnostic instruments, and have large resources to carry out multiple tests. Large number of tests are carried out on a daily basis in these centers which supports growth of the segment. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/1971 © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Market Trends Limited specificity of diagnostic tests available for infectious diseases triggers the need for combined diagnosis, which includes multiple tests. The trend of diagnosing a disease through multiple tests is gaining popularity. The market in North America is expected to witness significant growth, owing to increasing healthcare expenditure. For instance, according to the Centers for Medicare & Medicaid Services (CMS), health spending in the U.S. is projected to grow at an average rate of 5.5 percent per year for 2018-27 and to reach nearly US$ 6.0 trillion by 2027. However, the reimbursement scenario for diagnostic tests is comparatively poorer. Global Infectious Disease Diagnostics Market: Competitive Landscape Major players operating in the global infectious disease diagnostics market include, Becton Dickinson & Company, Cepheid, Inc., Abbott Laboratories, BioMerieux SA, Hologic, Inc., Danaher Corporation, Thermo Fisher Scientific, Inc., Roche Diagnostics, Alera Inc., DiaSorin S.p.A., Quidel Corporation, and Bio-Rad Laboratories, Inc.
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/1971 © Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.
SERVICES INDUSTRY ANALYSIS
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT CMI SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
Global Leading Equipment and System Manufacturers Marketing Consultancies and the Advertising Industry
Component Providers and System Integrators
Private and Government organization
Distributors, Retailors and Value Added Resellers
Outsourcing Companies
Healthcare IT Solutions Developers
Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY STUDIES
Insights Published Per Year
GLOBAL REPORTS
150+
Consulting Projects Till Date
COUNTRY ANALYSIS CONSULT PROJECTS
125+
Clients Worldwide Per Year
110+
SURVEY RESEARCH
EXCEL FORECAST DATABASE
CUSTOMIZED SOLUTIONS
COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702
© Coherent market Insights. All Rights Reserved